Clinical Trial Update: The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)

View source ↗

Summary

This document reports a completed clinical trial (BOCLA-Mort) evaluating optimization of clopidogrel-aspirin therapy in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Coronary Artery Disease | Status: COMPLETED